Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashley Sabus

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Clinical Pharmacy and Therapeutics|March 19, 2022
Ravulizumab 100 mg/mL formulation reduces infusion time and frequency, improving the patient and caregiver experience in the treatment of atypical haemolytic uraemic syndromeBradley P Dixon, Ashley Sabus
Pediatric Blood & Cancer|April 11, 2026
Safety and Efficacy of Romiplostim in Maintaining Chemotherapy Interval and Dose Intensity in Pediatric Patients With Solid Tumors and Chemotherapy-Induced ThrombocytopeniaErica Tonti, Ashley Sabus, Suzanne Smolik, et al.
Pharmacotherapy|February 23, 2019
Management of Self-injurious Behaviors in Children with Neurodevelopmental Disorders: A Pharmacotherapy OverviewAshley Sabus, James Feinstein, Patrick Romani, et al.
Pediatric Blood & Cancer|January 30, 2023
The incidence and characterization of weight gain associated with MEK inhibitors in pediatric patientsCassandra Rush, Ashley Sabus, Zanette Kanani Bradley, et al.
Journal of Pediatric Hematology/Oncology|December 4, 2020
Fecal Microbiota Transplantation for Treatment of Severe Clostridioides difficile Colitis in a Pediatric Patient With Non-Hodgkin LymphomaAshley Sabus, Mya Merrow, Alyssa Heiden, et al.
American Journal of Pharmaceutical Education|June 6, 2018
Using Continuing Professional Development to Create Meaningful Co-Curricular Learning Opportunities for all Student PharmacistsSusan S Vos, Ashley Sabus, Jennifer Seyfer, et al.
Pediatric Blood & Cancer|January 5, 2023
Thromboembolic toxicity observed with concurrent trametinib and lenalidomide therapyPriya P Chan, Ashley Sabus, Molly S Hemenway, et al.
Pediatric Pulmonology|April 24, 2019
Pathogen acquisition in patients with cystic fibrosis receiving ivacaftor or lumacaftor/ivacaftorSachinkumar B Singh, Amanda J McLearn-Montz, Francesca Milavetz, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Clinical Pharmacy and Therapeutics|March 19, 2022
Ravulizumab 100 mg/mL formulation reduces infusion time and frequency, improving the patient and caregiver experience in the treatment of atypical haemolytic uraemic syndromeBradley P Dixon, Ashley Sabus
Pediatric Blood & Cancer|April 11, 2026
Safety and Efficacy of Romiplostim in Maintaining Chemotherapy Interval and Dose Intensity in Pediatric Patients With Solid Tumors and Chemotherapy-Induced ThrombocytopeniaErica Tonti, Ashley Sabus, Suzanne Smolik, et al.
Pharmacotherapy|February 23, 2019
Management of Self-injurious Behaviors in Children with Neurodevelopmental Disorders: A Pharmacotherapy OverviewAshley Sabus, James Feinstein, Patrick Romani, et al.
Pediatric Blood & Cancer|January 30, 2023
The incidence and characterization of weight gain associated with MEK inhibitors in pediatric patientsCassandra Rush, Ashley Sabus, Zanette Kanani Bradley, et al.
Journal of Pediatric Hematology/Oncology|December 4, 2020
Fecal Microbiota Transplantation for Treatment of Severe Clostridioides difficile Colitis in a Pediatric Patient With Non-Hodgkin LymphomaAshley Sabus, Mya Merrow, Alyssa Heiden, et al.
American Journal of Pharmaceutical Education|June 6, 2018
Using Continuing Professional Development to Create Meaningful Co-Curricular Learning Opportunities for all Student PharmacistsSusan S Vos, Ashley Sabus, Jennifer Seyfer, et al.
Pediatric Blood & Cancer|January 5, 2023
Thromboembolic toxicity observed with concurrent trametinib and lenalidomide therapyPriya P Chan, Ashley Sabus, Molly S Hemenway, et al.
Pediatric Pulmonology|April 24, 2019
Pathogen acquisition in patients with cystic fibrosis receiving ivacaftor or lumacaftor/ivacaftorSachinkumar B Singh, Amanda J McLearn-Montz, Francesca Milavetz, et al.
Pageof 1